Structures by: Munshi P.
Total: 68
2-(4-methoxy-2,3-dimethylphenyl)-1H-benzo[d]imidazole, Water
C16H16N2O,0.5(H2O)
Organic letters (2016) 18, 13 3090-3093
a=12.441(4)Å b=8.216(2)Å c=26.040(7)Å
α=90° β=93.756(9)° γ=90°
C6H18N2,2(CNS)
C6H18N2,2(CNS)
The journal of physical chemistry. A (2007) 111, 32 7888-7897
a=5.8915(2)Å b=6.8875(2)Å c=8.2113(2)Å
α=73.8950(10)° β=79.2280(10)° γ=85.917(3)°
(Z)-5-(4-methylbenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=12.5012(6)Å b=16.1346(7)Å c=7.6541(4)Å
α=90° β=106.967(2)° γ=90°
(Z)-2-(piperidin-1-yl)-5-(2,4,5-trimethoxybenzylidene)thiazol-4(5H)-one
C18H22N2O4S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=10.0466(4)Å b=7.7834(3)Å c=22.9774(10)Å
α=90° β=93.920(2)° γ=90°
(Z)-5-(4-(dimethylamino)benzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C17H21N3OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=12.7194(4)Å b=8.0294(3)Å c=16.4422(6)Å
α=90° β=105.3040(10)° γ=90°
(Z)-5-(4-methoxybenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2O2S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=8.5748(3)Å b=16.5115(5)Å c=10.8532(4)Å
α=90° β=100.9220(10)° γ=90°
(Z)-2-(piperidin-1-yl)-5-(4-propoxybenzylidene)thiazol-4(5H)-one
C18H22N2O2S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=14.6019(6)Å b=15.8336(5)Å c=7.5085(3)Å
α=90° β=90.141(2)° γ=90°
(Z)-5-(2-methylbenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=19.808(2)Å b=19.648(2)Å c=7.5797(8)Å
α=90° β=95.378(4)° γ=90°
(Z)-5-(2,3-dimethoxybenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C17H20N2O3S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=6.9066(6)Å b=10.3537(10)Å c=12.5514(13)Å
α=96.955(4)° β=103.338(3)° γ=100.576(3)°
(Z)-5-(naphthalen-1-ylmethylene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C19H18N2OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=19.3839(6)Å b=7.7880(3)Å c=20.9133(8)Å
α=90° β=90° γ=90°
(Z)-5-(benzo[d][1,3]dioxol-4-ylmethylene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H16N2O3S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=8.3333(6)Å b=16.8148(12)Å c=10.7927(8)Å
α=90° β=103.960(2)° γ=90°
2-(p-tolyll)-1H-phenanthro[9,10-d]imidazole
C22H16N2
Chemical Communications (2019)
a=14.3222(6)Å b=14.3222(6)Å c=15.7591(7)Å
α=90° β=90° γ=90°
2-(p-tolyl)-1H-phenanthro[9,10-d]imidazole
C22H16N2
Chemical Communications (2019)
a=19.2160(4)Å b=19.2160(4)Å c=8.9740(2)Å
α=90° β=90° γ=90°
2-(p-tolyll)-1H-phenanthro[9,10-d]imidazole
C22H16N2
Chemical Communications (2019)
a=14.2215(2)Å b=14.2215(2)Å c=15.6241(2)Å
α=90° β=90° γ=90°
2-(p-tolyl)-1H-phenanthro[9,10-d]imidazole
C22H16N2
Chemical Communications (2019)
a=18.8380(7)Å b=9.8555(4)Å c=20.0216(7)Å
α=90° β=115.797(2)° γ=90°
2-(p-tolyll)-1H-phenanthro[9,10-d]imidazole
C22H16N2
Chemical Communications (2019)
a=14.3658(4)Å b=14.3658(4)Å c=15.8337(5)Å
α=90° β=90° γ=90°
2-(p-tolyll)-1H-phenanthro[9,10-d]imidazole
C22H16N2
Chemical Communications (2019)
a=14.510(15)Å b=14.510(15)Å c=15.944(11)Å
α=90° β=90° γ=90°
Indozolidinoindolones
C16H18N2O2
New J. Chem. (2015) 39, 12 9281
a=9.735(3)Å b=11.144(3)Å c=12.745(4)Å
α=90° β=90° γ=90°
Indozolidinoindolones
C16H18N2O2
New J. Chem. (2015) 39, 12 9281
a=9.821(8)Å b=11.174(8)Å c=12.954(10)Å
α=90° β=90° γ=90°
Spiroindolopyrrolizinones
C15H16N2O2
New J. Chem. (2015) 39, 12 9281
a=7.289(3)Å b=11.525(4)Å c=14.616(5)Å
α=90° β=91.587(19)° γ=90°
C29H25BN2
C29H25BN2
Chem.Commun. (2015) 51, 16115
a=17.3899(3)Å b=10.3122(2)Å c=26.5129(5)Å
α=90.00° β=108.4870(10)° γ=90.00°
C27H20BN
C27H20BN
Chem.Commun. (2015) 51, 16115
a=8.8980(4)Å b=7.0675(3)Å c=30.3620(14)Å
α=90.00° β=98.000(3)° γ=90.00°
C29H23BN2
C29H23BN2
Chem.Commun. (2015) 51, 16115
a=9.3145(5)Å b=9.7778(6)Å c=12.5665(7)Å
α=83.550(3)° β=84.896(3)° γ=76.744(3)°
C25H20BN
C25H20BN
Chem.Commun. (2015) 51, 16115
a=13.9351(7)Å b=9.0239(5)Å c=14.1194(8)Å
α=90.00° β=92.128(3)° γ=90.00°
C21H25BN2
C21H25BN2
Chem.Commun. (2015) 51, 16115
a=7.9636(2)Å b=8.8054(2)Å c=14.8492(5)Å
α=106.476(2)° β=90.570(2)° γ=116.512(2)°
C16H15N1O3
C16H15N1O3
CrystEngComm (2008) 10, 2 197
a=15.4037(3)Å b=13.4121(2)Å c=13.2831(2)Å
α=90° β=90° γ=90°
C16H15N1O3
C16H15N1O3
CrystEngComm (2008) 10, 2 197
a=7.2691(5)Å b=14.0308(12)Å c=26.229(2)Å
α=90° β=90° γ=90°
C16H15N1O3
C16H15N1O3
CrystEngComm (2008) 10, 2 197
a=11.8890(2)Å b=7.41180(10)Å c=15.6083(2)Å
α=90° β=103.661(2)° γ=90°
C32H25Cl2N5O7Ru
C32H25Cl2N5O7Ru
Journal of the Chemical Society, Dalton Transactions (2000) 14 2327
a=8.693(3)Å b=13.513(7)Å c=14.137(6)Å
α=99.88(4)° β=91.72(4)° γ=102.42(3)°
Pf17
C13H8BrNO3S,C5H9NO
RSC Adv. (2015)
a=7.4930(4)Å b=32.9156(16)Å c=7.6917(4)Å
α=90° β=104.704(2)° γ=90°
(Z)-5-(3-hydroxy-4-methoxybenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2O3S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=7.303(3)Å b=16.637(5)Å c=12.598(5)Å
α=90° β=97.725(13)° γ=90°
(Z)-5-(4-methoxy-2,3-dimethylbenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C18H22N2O2S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=13.1879(8)Å b=8.2959(4)Å c=16.8693(10)Å
α=90° β=111.933(2)° γ=90°
C10H10N3O3S,C5H7N2,0.5(H2O)
C10H10N3O3S,C5H7N2,0.5(H2O)
CrystEngComm (2017)
a=10.2001(18)Å b=11.201(2)Å c=15.778(3)Å
α=106.698(3)° β=91.809(3)° γ=101.329(4)°
C14H10F3NO2,C12H14N4O2S
C14H10F3NO2,C12H14N4O2S
CrystEngComm (2017)
a=15.889(2)Å b=14.854(2)Å c=22.217(3)Å
α=90.00° β=90.00° γ=90.00°
C12H13N4O2S,C5H7N2
C12H13N4O2S,C5H7N2
CrystEngComm (2017)
a=8.0233(13)Å b=14.923(3)Å c=15.703(3)Å
α=90.00° β=97.694(4)° γ=90.00°
C13H9F3N2O2,C12H14N4O2S
C13H9F3N2O2,C12H14N4O2S
CrystEngComm (2017)
a=15.840(2)Å b=14.613(2)Å c=21.829(3)Å
α=90.00° β=90.00° γ=90.00°
C10H10N3O3S,0.5(C4H12N2)
C10H10N3O3S,0.5(C4H12N2)
CrystEngComm (2017)
a=8.0883(15)Å b=8.2003(16)Å c=11.818(2)Å
α=108.255(3)° β=94.274(5)° γ=104.221(3)°
C11H11N4O2S,C5H7N2
C11H11N4O2S,C5H7N2
CrystEngComm (2017)
a=7.871(2)Å b=9.438(3)Å c=12.417(4)Å
α=101.990(6)° β=103.624(7)° γ=103.701(6)°
2(C11H11N4O2S),C4H12N2
2(C11H11N4O2S),C4H12N2
CrystEngComm (2017)
a=5.9301(9)Å b=13.886(2)Å c=18.557(3)Å
α=86.989(3)° β=81.358(3)° γ=82.556(3)°
C12H13N4O2S,0.5(C4H12N2)
C12H13N4O2S,0.5(C4H12N2)
CrystEngComm (2017)
a=6.2696(12)Å b=13.417(3)Å c=19.801(4)Å
α=90.00° β=94.890(4)° γ=90.00°
(Z)-3-(3,4-dimethoxyphenyl)-2-(4-nitrophenyl)acrylonitrile
C17H14N2O4
CrystEngComm (2016) 18, 43 8497
a=7.6956(2)Å b=12.3234(4)Å c=15.6647(5)Å
α=82.0790(10)° β=86.3800(10)° γ=84.4590(10)°
(Z)-3-(3,4-dimethoxyphenyl)-2-(4-nitrophenyl)acrylonitrile
C17H14N2O4
CrystEngComm (2016) 18, 43 8497
a=10.2321(4)Å b=11.9576(5)Å c=12.2700(5)Å
α=91.0010(10)° β=99.5610(10)° γ=100.1880(10)°
(Z)-3-(3,4-dimethoxyphenyl)-2-(4-nitrophenyl)acrylonitrile
C17H14N2O4
CrystEngComm (2016) 18, 43 8497
a=8.6636(4)Å b=11.9452(6)Å c=14.3305(7)Å
α=100.527(2)° β=90.917(2)° γ=95.640(2)°
[2](ClO4)2.H2O
[2](ClO4)2.H2O
Journal of the Chemical Society, Dalton Transactions (2002) 11 2348
a=33.660(5)Å b=15.466(2)Å c=21.098(3)Å
α=90.00° β=124.033(2)° γ=90.00°
1-formyl-3-thiosemicarbazide
C2H5N3OS
Acta Crystallographica Section B (2006) 62, 1 118-127
a=7.2569(17)Å b=7.4263(18)Å c=9.593(2)Å
α=90° β=98.606(4)° γ=90°
1-formyl-3-thiosemicarbazide
C2H5N3OS
Acta Crystallographica Section B (2006) 62, 1 118-127
a=7.2339(5)Å b=7.3703(5)Å c=9.4771(7)Å
α=90.00° β=98.4260(10)° γ=90.00°
1-Formyl-3-thiosemicarbazide
C2H5N3OS
Acta Crystallographica Section B (2006) 62, 1 118-127
a=7.2359(3)Å b=7.3713(3)Å c=9.4768(4)Å
α=90° β=98.403(2)° γ=90°
L-ornithine Hydrochloride
C5H13N2O2,Cl
Acta Crystallographica Section B (2007) 63, 3 505-509
a=9.9480(2)Å b=7.9637(2)Å c=4.98260(10)Å
α=90.0° β=83.130(10)° γ=90.0°
2-thiocoumarin
C9H6OS
Acta Crystallographica Section B (2002) 58, 6 1011-1017
a=4.0515(2)Å b=10.1749(7)Å c=17.6519(9)Å
α=90.000° β=90.000° γ=90.000°
Quercetin monohydrate
C15H10O7,H2O
Acta Crystallographica Section B (2011) 67, 1 63-78
a=8.7370(10)Å b=4.8520(10)Å c=30.1600(10)Å
α=90.00° β=95.520(10)° γ=90.00°
Quercetin monohydrate
C15H10O7,H2O
Acta Crystallographica Section B (2011) 67, 1 63-78
a=8.7370(10)Å b=4.8520(10)Å c=30.1600(10)Å
α=90.00° β=95.520(10)° γ=90.00°
Quercetin monohydrate
C15H10O7,H2O
Acta Crystallographica Section B (2011) 67, 1 63-78
a=8.7370(10)Å b=4.8520(10)Å c=30.1600(10)Å
α=90.00° β=95.520(10)° γ=90.00°
Salicylic acid
C7H6O3
Acta Crystallographica Section B (2006) 62, 4 612-626
a=4.8818(2)Å b=11.2009(5)Å c=11.2335(5)Å
α=90° β=92.621(2)° γ=90°
2-thiouracil
C4H4N2OS
Acta Crystallographica Section B (2006) 62, 4 612-626
a=4.2427(4)Å b=5.9648(5)Å c=10.5801(10)Å
α=105.736(5)° β=94.912(5)° γ=91.927(4)°
Cytosine Monohydrate
C4H5N3O,H2O
Acta Crystallographica Section B (2006) 62, 4 612-626
a=7.7161(8)Å b=9.8337(10)Å c=7.5131(8)Å
α=90° β=100.523(5)° γ=90°
1-thiocoumarin
C9H6OS
Acta Crystallographica Section E (2002) 58, 4 o353-o354
a=3.8899(5)Å b=8.4355(11)Å c=11.4569(15)Å
α=90.00° β=96.530(5)° γ=90.00°
2-thiocoumarin
C9H6OS
Acta Crystallographica Section E (2001) 57, 12 o1175-o1176
a=4.1260(10)Å b=17.779(3)Å c=10.268(3)Å
α=90° β=90° γ=90°
Dithiocoumarin
C9H6S2
Acta Crystallographica Section E (2004) 60, 11 o2168-o2170
a=7.4427(13)Å b=7.5697(13)Å c=8.2490(14)Å
α=83.270(2)° β=67.445(2)° γ=65.599(2)°
L-Valinol
C5H13NO
Acta Crystallographica Section C (2006) 62, 11 o633-o635
a=4.8154(9)Å b=8.518(5)Å c=15.624(5)Å
α=90.0° β=90.0° γ=90.0°
C12H11N2O5Cl1S1,0.5(C10N2H8)
C12H11N2O5Cl1S1,0.5(C10N2H8)
Crystal Growth & Design (2015) 15, 12 5858
a=11.4746(2)Å b=9.6630(2)Å c=16.1003(3)Å
α=90° β=101.2150(10)° γ=90°
C12H11ClN2O5S,0.5(C10H8N2)
C12H11ClN2O5S,0.5(C10H8N2)
Crystal Growth & Design (2015) 15, 12 5858
a=25.981(5)Å b=6.5254(13)Å c=21.043(4)Å
α=90° β=107.372(3)° γ=90°
(C12H11ClN2O5S,C5H6N2)
(C12H11ClN2O5S,C5H6N2)
Crystal Growth & Design (2015) 15, 12 5858
a=8.5913(2)Å b=12.9773(3)Å c=17.6723(4)Å
α=84.4360(10)° β=84.9390(10)° γ=75.4550(10)°
C39H34Cl2N7O10S2
C39H34Cl2N7O10S2
Crystal Growth & Design (2015) 15, 12 5858
a=10.2035(2)Å b=14.0538(3)Å c=15.1873(3)Å
α=107.1600(10)° β=107.3050(10)° γ=91.4320(10)°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2006) 6, 3 708
a=7.4772(15)Å b=9.6304(19)Å c=11.9893(2)Å
α=85.751(11)° β=86.099(11)° γ=81.753(11)°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2006) 6, 3 708
a=11.3068(7)Å b=3.9871(2)Å c=18.7586(11)Å
α=90.00° β=90.454(2)° γ=90.00°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2004) 4, 6 1105
a=11.325(7)Å b=3.987(2)Å c=18.773(11)Å
α=90° β=90.425(10)° γ=90°
3-acetylcoumarin
C11H8O3
Crystal Growth & Design (2004) 4, 6 1105
a=7.496(4)Å b=9.653(6)Å c=12.002(7)Å
α=85.740(9)° β=86.097(9)° γ=81.728(9)°
2,5-dichloro 1,4-benzoquinone
C6H2Cl2O2
Crystal Growth & Design (2011) 11, 5 1855
a=6.0187(3)Å b=5.3451(3)Å c=9.9651(4)Å
α=90° β=92.604(2)° γ=90°